Skip to content
MedsAcross

Molecule

Zoonotic influenza vaccine (h5n8) (surface antigen, inactivated, adjuvanted)

BiologicVaccines
Presentations
0
Brands
0
Manufacturers
0
Available from stock
0

Zoonotic influenza vaccine (h5n8) (surface antigen, inactivated, adjuvanted) is a medicine. It is available for export supply from India to licensed hospitals, importers and physicians, with the documents the destination country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Key facts

ATC classification
J07BB02 Influenza vaccine (surface antigen, inactivated, adjuvanted) · Influenza vaccine
US FDA first approval
Not recorded
EU status
Authorised
Orphan designation
No
WHO essential medicine
Not recorded
India (CDSCO)
Not yet confirmed against CDSCO approval lists
Biologic
Yes

All presentations

No presentations of Zoonotic influenza vaccine (h5n8) (surface antigen, inactivated, adjuvanted) are listed yet. Ask us to source it

Regulatory status

Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.

RegisterStatusSource
US FDANot recorded—
EU (EMA)AuthorisedEMA medicines data
India (CDSCO)Not yet confirmed against CDSCO approval lists—
AustriaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
BelgiumRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
BulgariaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CroatiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CyprusRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CzechiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
DenmarkRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
EstoniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
FinlandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
FranceRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
GermanyRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
GreeceRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
HungaryRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
IcelandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
IrelandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
ItalyRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LatviaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LiechtensteinRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LithuaniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LuxembourgRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
MaltaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
NetherlandsRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
NorwayRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
PolandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
PortugalRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
RomaniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SlovakiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SloveniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SpainRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SwedenRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026

Questions and answers

Is Zoonotic influenza vaccine (h5n8) (surface antigen, inactivated, adjuvanted) available for export from India?

No presentation of Zoonotic influenza vaccine (h5n8) (surface antigen, inactivated, adjuvanted) is listed yet, but our sourcing team can check licensed channels. Send a request with the strength, quantity and destination country.

Is Zoonotic influenza vaccine (h5n8) (surface antigen, inactivated, adjuvanted) authorised in the European Union?

Yes. Zoonotic influenza vaccine (h5n8) (surface antigen, inactivated, adjuvanted) has a central EU marketing authorisation (status: authorised), according to European Medicines Agency data.

Does Zoonotic influenza vaccine (h5n8) (surface antigen, inactivated, adjuvanted) need cold chain shipping?

No listed presentation of Zoonotic influenza vaccine (h5n8) (surface antigen, inactivated, adjuvanted) is recorded as needing a cold chain. Storage conditions are shown on each presentation page.

Which ATC class is Zoonotic influenza vaccine (h5n8) (surface antigen, inactivated, adjuvanted) in?

Zoonotic influenza vaccine (h5n8) (surface antigen, inactivated, adjuvanted) is classified under ATC code J07BB02 (Influenza vaccine (surface antigen, inactivated, adjuvanted)).

References

  1. Zoonotic Influenza Vaccine Seqirus: European public assessment report (EPAR). European Medicines Agency. Retrieved 27 June 2025

Request Zoonotic influenza vaccine (h5n8) (surface antigen, inactivated, adjuvanted) for export supply

Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.